HomeACRS • NASDAQ
add
Aclaris Therapeutics Inc
Previous close
$3.51
Day range
$3.47 - $3.63
Year range
$1.05 - $4.89
Market cap
426.91M USD
Avg Volume
2.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.30M | -85.94% |
Operating expense | 2.32M | -15.97% |
Net income | -19.80M | 79.50% |
Net profit margin | -1.53K | -45.83% |
Earnings per share | -0.16 | 84.16% |
EBITDA | -22.32M | -59.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 90.75M | -20.11% |
Total assets | 160.46M | -27.17% |
Total liabilities | 57.38M | -11.42% |
Total equity | 103.08M | — |
Shares outstanding | 120.60M | — |
Price to book | 4.08 | — |
Return on assets | -33.24% | — |
Return on capital | -49.08% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -19.80M | 79.50% |
Cash from operations | -13.13M | -46.91% |
Cash from investing | 10.37M | 111.69% |
Cash from financing | -2.53M | -103.40% |
Net change in cash | -5.30M | 77.05% |
Free cash flow | -8.84M | 75.83% |
About
Founded
2012
Website
Employees
71
